Raymond James & Associates Azenta, Inc. Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Azenta, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 77,105 shares of AZTA stock, worth $3.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
77,105
Previous 110,948 30.5%
Holding current value
$3.48 Million
Previous $5.84 Million 36.04%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
SELL
$45.84 - $62.29 $1.55 Million - $2.11 Million
-33,843 Reduced 30.5%
77,105 $3.73 Million
Q2 2024

Jul 19, 2024
BUY
$50.27 - $59.04 $29,860 - $35,069
594 Added 0.54%
110,948 $5.84 Million
Q1 2024

Apr 22, 2024
BUY
$57.82 - $67.51 $822,662 - $960,532
14,228 Added 14.8%
110,354 $6.65 Million
Q4 2023

Jan 16, 2024
BUY
$44.02 - $66.3 $12,545 - $18,895
285 Added 0.3%
96,126 $6.26 Million
Q3 2023

Oct 24, 2023
SELL
$44.08 - $57.76 $132,636 - $173,799
-3,009 Reduced 3.04%
95,841 $4.81 Million
Q2 2023

Jul 25, 2023
SELL
$36.45 - $46.68 $27,009 - $34,589
-741 Reduced 0.74%
98,850 $4.61 Million
Q1 2023

Apr 14, 2023
BUY
$39.51 - $61.95 $1.34 Million - $2.11 Million
34,005 Added 51.85%
99,591 $4.44 Million
Q4 2022

Feb 08, 2023
BUY
$38.6 - $62.07 $273,056 - $439,083
7,074 Added 12.09%
65,586 $3.82 Million
Q3 2022

Oct 25, 2022
BUY
$42.86 - $77.02 $676,202 - $1.22 Million
15,777 Added 36.92%
58,512 $2.51 Million
Q2 2022

Aug 12, 2022
BUY
$64.69 - $85.07 $21,994 - $28,923
340 Added 0.8%
42,735 $3.08 Million
Q1 2022

May 11, 2022
SELL
$76.3 - $103.81 $2.24 Million - $3.05 Million
-29,418 Reduced 40.96%
42,395 $3.51 Million
Q4 2021

Feb 08, 2022
BUY
$92.98 - $124.15 $88,888 - $118,687
956 Added 1.35%
71,813 $7.41 Million
Q3 2021

Nov 02, 2021
BUY
$77.49 - $109.17 $1.75 Million - $2.47 Million
22,618 Added 46.89%
70,857 $7.25 Million
Q2 2021

Aug 11, 2021
BUY
$86.59 - $107.47 $261,328 - $324,344
3,018 Added 6.67%
48,239 $4.6 Million
Q1 2021

May 14, 2021
BUY
$66.32 - $90.93 $1.87 Million - $2.56 Million
28,123 Added 164.48%
45,221 $3.69 Million
Q4 2020

Feb 12, 2021
BUY
$46.7 - $75.22 $23,957 - $38,587
513 Added 3.09%
17,098 $1.16 Million
Q3 2020

Nov 04, 2020
SELL
$42.77 - $56.69 $1.14 Million - $1.51 Million
-26,688 Reduced 61.67%
16,585 $767,000
Q2 2020

Jul 28, 2020
SELL
$26.54 - $44.24 $284,588 - $474,385
-10,723 Reduced 19.86%
43,273 $1.91 Million
Q1 2020

Apr 21, 2020
BUY
$22.69 - $44.14 $766,332 - $1.49 Million
33,774 Added 167.02%
53,996 $1.65 Million
Q4 2019

Feb 12, 2020
SELL
$35.49 - $48.05 $21,116 - $28,589
-595 Reduced 2.86%
20,222 $848,000
Q3 2019

Nov 07, 2019
SELL
$30.18 - $41.75 $2,776 - $3,841
-92 Reduced 0.44%
20,817 $771,000
Q2 2019

Aug 06, 2019
SELL
$29.53 - $41.1 $59,562 - $82,898
-2,017 Reduced 8.8%
20,909 $810,000
Q1 2019

May 06, 2019
BUY
$24.38 - $33.75 $43,055 - $59,602
1,766 Added 8.35%
22,926 $672,000
Q4 2018

Feb 11, 2019
SELL
$23.22 - $35.29 $1.03 Million - $1.56 Million
-44,193 Reduced 67.62%
21,160 $554,000
Q3 2018

Nov 14, 2018
BUY
$28.71 - $39.6 $1.06 Million - $1.46 Million
36,770 Added 128.64%
65,353 $2.29 Million
Q2 2018

Aug 14, 2018
BUY
$24.88 - $36.36 $377,429 - $551,581
15,170 Added 113.1%
28,583 $932,000
Q1 2018

May 14, 2018
BUY
$23.3 - $30.15 $312,522 - $404,401
13,413 New
13,413 $363,000
Q4 2017

Feb 14, 2018
SELL
$22.54 - $34.39 $915,191 - $1.4 Million
-40,603 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$22.6 - $30.36 $438,666 - $589,287
19,410 Added 91.59%
40,603 $1.23 Million
Q2 2017

Aug 14, 2017
BUY
N/A
21,193
21,193 $460,000

Others Institutions Holding AZTA

# of Institutions
336
Shares Held
49.4M
Call Options Held
186K
Put Options Held
405K
View Full List

About Azenta, Inc.

AZTA Quotes by TradingView
  • Ticker AZTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 75,020,400
  • Market Cap $3.39B
  • Description
  • Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...
More about AZTA
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email